XT
NGNE icon

XTX Topco’s Neurogene NGNE Stock Holding History

XTX Topco’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$553K Buy
+27,431
New +$531K 0.01% 1956
2025
Q4 		– Sell
-12,000
Closed -$208K – 3636
2025
Q3 		$208K Buy
+12,000
New +$241K 0.01% 1816
2025
Q1 		– Sell
-15,256
Closed -$349K – 2853
2024
Q4 		$349K Buy
+15,256
New +$568K 0.03% 1090
2022
Q1 		– Sell
-501
Closed -$48K – 870
2021
Q4 		$48K Buy
+501
New +$61K 0.03% 569

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

XTX Topco's NGNE Position: Q1 2026 in Review

XTX Topco opened a new position in Neurogene (NGNE) in Q1 2026: 27,431 shares worth $553K. The stake represents 0.01% of the portfolio and ranks #1956 among its holdings. This is a return to the name: XTX Topco previously reported a position in NGNE as recently as Q3 2025.

XTX Topco first reported a position in NGNE in Q4 2021 and has held it in 4 quarters since. 96 funds tracked by Wall St. Rank hold NGNE as of Q1 2026.

  • XTX Topco held 27,431 shares of Neurogene worth $553K as of Q1 2026.
  • Neurogene was a new XTX Topco position in Q1 2026.
  • Neurogene made up 0.01% of XTX Topco's portfolio in Q1 2026, its #1956 holding.
  • XTX Topco first reported a position in Neurogene in Q4 2021 and has held it in 4 quarters since.
  • 96 funds tracked by Wall St. Rank held Neurogene as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.